Masimo Corporation (MASI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MASI Revenue Growth
Revenue Breakdown (FY 2025)
MASI's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
MASI Revenue Analysis (2014–2025)
As of May 7, 2026, Masimo Corporation (MASI) generated trailing twelve-month (TTM) revenue of $1.56 billion, reflecting solid growth of +8.5% year-over-year. The most recent quarter (Q1 2026) recorded $403.6 million in revenue, down 2.2% sequentially.
Looking at the longer-term picture, MASI's 5-year compound annual growth rate (CAGR) stands at +5.9%, indicating steady revenue expansion. The company achieved its highest annual revenue of $2.09 billion in 2024.
Revenue diversification analysis shows MASI's business is primarily driven by Health Care Segment (100%). With over half of revenue concentrated in Health Care Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including PODD (+31.9% YoY), HOLX (+2.2% YoY), and NVCR (+8.5% YoY), MASI has underperformed the peer group in terms of revenue growth. Compare MASI vs PODD →
MASI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MASICurrent | $1.6B | +8.5% | +5.9% | 20.5% | |
 PODD | $2.7B | +31.9% | +24.5% | 17.5% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ITGR | $1.8B | +6.0% | +11.5% | 11.3% | |
 ICUI | $2.2B | -0.8% | +11.9% | 1.9% |
MASI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.53B | -27.1% | $945.2M | 61.9% | $312.8M | 20.5% |
| 2024 | $2.09B | +2.3% | $1.00B | 48.0% | $-266,700,000 | -12.7% |
| 2023 | $2.05B | +0.6% | $1.00B | 49.0% | $136.5M | 6.7% |
| 2022 | $2.04B | +64.3% | $1.06B | 52.0% | $210.0M | 10.3% |
| 2021 | $1.24B | +8.4% | $808.4M | 65.2% | $275.8M | 22.3% |
| 2020 | $1.14B | +22.0% | $743.0M | 65.0% | $255.8M | 22.4% |
| 2019 | $937.8M | +9.3% | $629.2M | 67.1% | $221.2M | 23.6% |
| 2018 | $858.3M | +8.6% | $574.9M | 67.0% | $208.0M | 24.2% |
| 2017 | $790.2M | +10.9% | $522.0M | 66.1% | $183.8M | 23.3% |
| 2016 | $712.9M | +13.1% | $478.3M | 67.1% | $435.9M | 61.2% |
See MASI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MASI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MASI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMASI — Frequently Asked Questions
Quick answers to the most common questions about buying MASI stock.
Is MASI's revenue growth accelerating or slowing?
MASI maintains +8.5% revenue growth, in line with its 5-year CAGR of +5.9%. TTM revenue stands at $1.6B. Growth rate remains consistent with historical average.
What is MASI's long-term revenue growth rate?
Masimo Corporation's 5-year revenue CAGR of +5.9% reflects the sustained expansion pattern. Current YoY growth of +8.5% is near this long-term average.
How is MASI's revenue distributed by segment?
MASI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.